NCT05677048View on ClinicalTrials.gov

Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention

NAActive, not recruitingINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

April 14, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2027

Conditions
Gynecologic CancerOvary CancerPancreatic CancerBreast CancerLynch SyndromeHereditary Breast and Ovarian Cancer SyndromeColon CancerEndometrial CancerUterus Cancer
Interventions
BEHAVIORAL

Free genetic testing and counseling group

Option to access no-cost telegenetic counseling and genetic testing

BEHAVIORAL

IGNITE-TX Group

Access online educational materials through the IGNITE-TX platform and receive assistance from a family genetic navigator

BEHAVIORAL

IGNITE-TX and free genetic testing and counseling group

Option to access no-cost telegenetic counseling and genetic testing, access to online educational materials through the IGNITE-TX platform, and assistance from a family genetic navigator

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER